vs
Side-by-side financial comparison of Axos Financial, Inc. (AX) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
Axos Financial, Inc. is the larger business by last-quarter revenue ($392.2M vs $270.8M, roughly 1.4× HUTCHMED (China) Ltd). Axos Financial, Inc. runs the higher net margin — 31.8% vs 0.7%, a 31.1% gap on every dollar of revenue.
Axos Financial is an American bank holding company based in Las Vegas, Nevada and is the parent of Axos Bank, a direct bank. It also offers registered investment adviser services and an electronic trading platform.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
AX vs HCM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $392.2M | $270.8M |
| Net Profit | $124.7M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | — | -13.2% |
| Net Margin | 31.8% | 0.7% |
| Revenue YoY | — | -16.5% |
| Net Profit YoY | 18.5% | -83.6% |
| EPS (diluted) | $2.15 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $392.2M | — | ||
| Q4 25 | $385.1M | $270.8M | ||
| Q3 25 | $323.4M | — | ||
| Q2 25 | $321.4M | $277.7M | ||
| Q1 25 | $308.8M | $324.5M | ||
| Q4 24 | $307.9M | — | ||
| Q3 24 | $320.7M | — | ||
| Q2 24 | $290.9M | $305.7M |
| Q1 26 | $124.7M | — | ||
| Q4 25 | $128.4M | $2.0M | ||
| Q3 25 | $112.4M | — | ||
| Q2 25 | $110.7M | $455.0M | ||
| Q1 25 | $105.2M | $11.9M | ||
| Q4 24 | $104.7M | — | ||
| Q3 24 | $112.3M | — | ||
| Q2 24 | $104.9M | $25.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% |
| Q1 26 | — | — | ||
| Q4 25 | 45.6% | -13.2% | ||
| Q3 25 | 46.3% | — | ||
| Q2 25 | 48.5% | -1.3% | ||
| Q1 25 | 47.9% | -5.0% | ||
| Q4 24 | 48.8% | — | ||
| Q3 24 | 49.6% | — | ||
| Q2 24 | 49.6% | -9.0% |
| Q1 26 | 31.8% | — | ||
| Q4 25 | 33.3% | 0.7% | ||
| Q3 25 | 34.7% | — | ||
| Q2 25 | 34.4% | 163.8% | ||
| Q1 25 | 34.1% | 3.7% | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 36.0% | 8.4% |
| Q1 26 | $2.15 | — | ||
| Q4 25 | $2.22 | $0.00 | ||
| Q3 25 | $1.94 | — | ||
| Q2 25 | $1.89 | $0.52 | ||
| Q1 25 | $1.81 | $0.01 | ||
| Q4 24 | $1.80 | — | ||
| Q3 24 | $1.93 | — | ||
| Q2 24 | $1.75 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $3.1B | $1.2B |
| Total Assets | $29.2B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $1.9B | $1.4B | ||
| Q1 25 | $2.0B | $836.1M | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.0B | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | $312.7M | $93.4M | ||
| Q1 25 | $377.4M | $82.8M | ||
| Q4 24 | $358.7M | — | ||
| Q3 24 | $313.5M | — | ||
| Q2 24 | $325.7M | $82.1M |
| Q1 26 | $3.1B | — | ||
| Q4 25 | $2.9B | $1.2B | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.7B | $1.2B | ||
| Q1 25 | $2.6B | $759.9M | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.3B | $740.1M |
| Q1 26 | $29.2B | — | ||
| Q4 25 | $28.2B | $1.8B | ||
| Q3 25 | $27.4B | — | ||
| Q2 25 | $24.8B | $1.8B | ||
| Q1 25 | $24.0B | $1.3B | ||
| Q4 24 | $23.7B | — | ||
| Q3 24 | $23.6B | — | ||
| Q2 24 | $22.9B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.12× | 0.08× | ||
| Q1 25 | 0.14× | 0.11× | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $8.2M | ||
| Q3 25 | $118.4M | — | ||
| Q2 25 | $490.3M | $-72.9M | ||
| Q1 25 | $73.7M | $40.3M | ||
| Q4 24 | $162.5M | — | ||
| Q3 24 | $70.8M | — | ||
| Q2 24 | $305.5M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | $85.4M | $3.4M | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | $436.1M | $-82.2M | ||
| Q1 25 | $65.1M | $32.5M | ||
| Q4 24 | $156.4M | — | ||
| Q3 24 | $53.0M | — | ||
| Q2 24 | $269.5M | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | 22.2% | 1.2% | ||
| Q3 25 | 33.8% | — | ||
| Q2 25 | 135.7% | -29.6% | ||
| Q1 25 | 21.1% | 10.0% | ||
| Q4 24 | 50.8% | — | ||
| Q3 24 | 16.5% | — | ||
| Q2 24 | 92.6% | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 1.8% | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 16.9% | 3.3% | ||
| Q1 25 | 2.8% | 2.4% | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 12.4% | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | 4.21× | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | 4.43× | -0.16× | ||
| Q1 25 | 0.70× | 3.38× | ||
| Q4 24 | 1.55× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | 2.91× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
HCM
Segment breakdown not available.
